Skip to content

    Shiv Texchem

    544272
    Chemicals·6 Jun 2025
    Management Summary

    Shiv Texchem reported a strong H2 and FY25, with significant revenue and profit growth driven by both existing products and new SKU additions. EBITDA margins expanded to 4.4% in H2, exceeding expectations. While management emphasized sustainable growth in niche chemicals, concerns were raised regarding increased receivable days and the need for a potential fundraise to support future expansion.

    Highlights

    5

    • H2 revenue growth of 14-15% over H1, demonstrating strong operational performance.

    • H2 PAT growth of 35% and PBT growth of 40-50% over H1, indicating robust profitability.

    • H2 EBITDA margins at 4.4% surpassed management's expectation of 4.25%, reflecting improved efficiency.

    • FY25 saw significant revenue growth of 40-45% and EBITDA growth of over 50% compared to FY24, with EBITDA margins maintained above 4%.

    • Management highlighted a focus on sustainable growth through diversification into niche, specialized chemicals and continuous addition of new SKUs, targeting 75-80 products in 3-5 years.

    Concerns

    3

    • Receivable days increased from 40-43 days to 70-75 days, raising questions about working capital efficiency.

    • A potential fundraise is under internal discussion to support future growth, suggesting current internal accruals might not fully cover expansion needs.

    • Analysts raised concerns about the sustainability of growth in niche products and the risk of customers bypassing Shiv Texchem for direct sourcing as volumes increase.

    Key financials

    Metrics

    9

    Periods

    4

    Headline

    2
    • H2 EBITDA Margin
      4.4%
    • Receivable Days
      70 days

    FY25

    2
    • EBITDA Margin
      4%
    • PAT Margin
      1.9%

    vs FY24

    2
    • FY25 Revenue Growth
      40%
    • FY25 EBITDA Growth
      50%

    vs H1

    3
    • H2 Revenue Growth
      14.0%
    • H2 PAT Growth
      35%
    • H2 PBT Growth
      40%

    Guidance & targets

    4
    CategoryTargetPriority
    Revenue
    Revenue Growth CAGR
    40-45%
    		High
    Margin
    EBITDA Margin
    >4%
    		High
    Margin
    PAT Margin
    1.9-2.2%
    		High
    Product Portfolio
    Number of SKUs
    75-80 products
    		Medium

    Fundraise Plan Announcement

    next quarter
    CurrentUnder internal discussion
    TargetAnnouncement of specific fundraise plan (amount, type, timeline)

    Why it matters

    Will indicate the company's capital needs and strategy for funding future growth and expansion.

    So, sir, we are still internally discussing this with the board and the committees. So, on that one, we'll get back to you📌 as and when we do plan that.

    How to verify

    guidance_and_targets

    Risks & concerns

    3
    RiskSeverity

    Increased Receivable Days

    Receivable days increased from 40-43 to 70-75 days, though management states debtors are highly rated and it's a rebalancing of working capital cycles. — Analyst acknowledged

    medium

    Customer Disintermediation for Niche Products

    Risk of customers bypassing Shiv Texchem for direct sourcing as their volumes of niche products grow, potentially impacting future growth. — Analyst acknowledged

    medium

    Need for Fundraise to Support Growth

    A potential fundraise is under internal discussion to support future growth, indicating that current internal accruals might not be sufficient for aggressive expansion plans. — Analyst acknowledged

    low

    Q&A highlights

    8

    “the amount of petrochemicals imported in the country would be well into $20, $30 billion. And I'm just speaking about liquid petrochemicals, but for us focusing on highly niche specific chemicals, it already the addressable market is very large and the pie itself is expected to enhance. And we do not see the focus of any domestic sort of production coming in to fulfill these needs.”

    Clarifies the company's market positioning and long-term growth rationale in a niche, specialized chemical segment.

    asked by Nikhil Chandak

    2 min read5 chapters

    Detailed Narrative

    01

    Strong H2 & FY25 Financial Performance

    Shiv Texchem delivered a robust performance in H2 FY25, with revenue growing 14-15% over H1, PAT increasing by 35%, and PBT by 40-50%. The company's EBITDA margins reached 4.4% in H2, exceeding its internal expectation of 4.25%. For the full fiscal year FY25, revenue grew significantly by 40-45% compared to FY24, accompanied by an EBITDA growth of over 50% and sustained EBITDA margins above 4%. PAT margins for FY25 also expanded from 1.9% to 2.2%.

    02

    Niche Chemical Distribution Model and Competitive Moat

    The company operates in the niche chemical distribution space, addressing India's reliance on imported petrochemicals, a market estimated at $20-30 billion. Shiv Texchem differentiates itself through proprietary models for indicative pricing, real-time supply chain visibility, and specialized storage facilities for hazardous materials. Management emphasized that their focus on highly niche and specialized chemicals, where domestic production is limited, provides a sustainable growth runway and acts as a significant entry barrier for competitors.

    03

    Growth Drivers and Product Portfolio Expansion

    Shiv Texchem's growth is driven by a dual strategy: continued expansion of existing product volumes and the constant addition of new, specialized SKUs. The company has grown its product portfolio from 5-10 products to over 40 and aims to reach 75-80 products within the next 3-5 financial years. This diversification strategy, particularly into high-value-added niche products, is expected to enhance margins and strengthen market position, with identified growth pockets in specialty polymers, renewables, EV, electronics, and agrochemicals.

    04

    Working Capital Dynamics and Management

    A key discussion point was the increase in receivable days from 40-43 to 70-75 days. Management clarified this as a 'rebalancing of working capital cycles,' noting that inventory days have simultaneously dropped. They assured that most debtors are highly rated (CRISIL A and above), mitigating credit risk. Despite being an asset-light distribution business, management acknowledged that sustained revenue growth necessitates an increase in working capital, which is a function of current assets.

    05

    Future Outlook and Strategic Focus

    The company projects a sustainable revenue growth CAGR of 40-45% going forward⏳, with expectations for steady, trickling increases in EBITDA margins driven by benefits of scale and a richer product mix. Management reiterated its commitment to responsible, sustainable growth, avoiding lopsided exposure to any single product family or customer. A potential fundraise is currently under internal discussion to support future growth, with details to be disclosed upon finalization.

    This is an AI-generated summary of a publicly available earnings call transcript. It is for informational purposes only and does not constitute investment advice, a recommendation, or an endorsement. inve.money is not a SEBI-registered investment advisor. Please consult a qualified financial advisor before making any investment decisions.